Methotrexate Injection, Solution
Product Images NDC 61703-350

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Methotrexate (NDC 61703-350). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Methotrexate 01

Chemical structure of Methotrexate, illustrating the molecular arrangement of atoms in the active ingredient. The structure includes a pteridine core, an amino group, and side chains showing carboxyl groups typical of methotrexate's composition.*

FDA Label Image

Methotrexate 02

FDA Label Image

Methotrexate 03

FDA Label Image

Methotrexate 04

Label for Methotrexate Injection, USP 50 mg per 2 mL (25 mg/mL) isotonic liquid in a 2 mL sterile solution. The label includes warnings about preservative and cytotoxic content, distribution by Hospira, Inc., and a barcode. Routes include intramuscular, intravenous, and subcutaneous administration.*

FDA Label Image

Methotrexate 05

Packaging label for Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL) isotonic liquid in a multiple-dose vial. The label indicates the product is a hazardous drug for intravenous, intramuscular, and subcutaneous use, labeled by Hospira, Inc. The package includes warnings about preservative content and restricted uses.*

FDA Label Image

Methotrexate 06

Label for Methotrexate Injection, USP 1 g/40 mL (25 mg/mL) preservative-free solution by Hospira, Inc. The 40 mL single-dose vial is for intravenous, intramuscular, subcutaneous, and intrathecal use. It is marked as a hazardous drug and dispensed Rx only. The label includes storage instructions and a barcode.*

FDA Label Image

Methotrexate 07

Methotrexate Injection, USP 1 g/40 mL (25 mg/mL) vial label. The label indicates it is preservative free and intended for intravenous, intramuscular, subcutaneous, and intrathecal use. Manufactured by Hospira, Inc., this single-dose vial label includes warnings, storage instructions, and a barcode on a predominantly white background with purple and red text elements, marked as a hazardous drug.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.